Gritstone bio Inc. (GRTS): Skating on Thin Ice? We Know the Answer – News Heater
Home  »  Companies   »  Gritstone bio Inc. (GRTS): Skating on Thin Ice? We...

Gritstone bio Inc. (GRTS): Skating on Thin Ice? We Know the Answer

Gritstone bio Inc. (NASDAQ:GRTS) went up by 6.30% from its latest closing price compared to the recent 1-year high of $14.42. The company’s stock price has collected 20.48% of gains in the last five trading sessions. The Wall Street Journal reported on 01/19/21 that Tesla, GameStop, Coherent: What to Watch When the Stock Market Opens Today

Is It Worth Investing in Gritstone bio Inc. (NASDAQ :GRTS) Right Now?

Plus, the 36-month beta value for GRTS is at 0.60.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


GRTS currently public float of 70.65M and currently shorts hold a 5.94% ratio of that float. Today, the average trading volume of GRTS was 1.20M shares.

GRTS’s Market Performance

GRTS stocks went up by 20.48% for the week, with a monthly jump of 30.41% and a quarterly performance of -45.36%, while its annual performance rate touched -72.77%. The volatility ratio for the week stands at 9.74% while the volatility levels for the past 30 days are set at 9.00% for Gritstone bio Inc. The simple moving average for the period of the last 20 days is 21.50% for GRTS stocks with a simple moving average of -63.95% for the last 200 days.

Analysts’ Opinion of GRTS

Many brokerage firms have already submitted their reports for GRTS stocks, with Goldman repeating the rating for GRTS by listing it as a “Neutral.” The predicted price for GRTS in the upcoming period, according to Goldman is $15 based on the research report published on December 15th of the previous year 2021.

BTIG Research, on the other hand, stated in their research note that they expect to see GRTS reach a price target of $20. The rating they have provided for GRTS stocks is “Buy” according to the report published on October 15th, 2021.

Robert W. Baird gave a rating of “Underperform” to GRTS, setting the target price at $8 in the report published on January 20th of the previous year.

GRTS Trading at 1.65% from the 50-Day Moving Average

After a stumble in the market that brought GRTS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.45% of loss for the given period.

Volatility was left at 9.00%, however, over the last 30 days, the volatility rate increased by 9.74%, as shares surge +28.43% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -31.99% lower at present.

During the last 5 trading sessions, GRTS rose by +20.48%, which changed the moving average for the period of 200-days by -76.94% in comparison to the 20-day moving average, which settled at $2.11. In addition, Gritstone bio Inc. saw -80.33% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at GRTS starting from Jones Erin, who sale 1,000 shares at the price of $13.01 back on Dec 01. After this action, Jones Erin now owns 45,900 shares of Gritstone bio Inc., valued at $13,010 using the latest closing price.

Jones Erin, the of Gritstone bio Inc., sale 1,000 shares at $11.14 during a trade that took place back on Nov 01, which means that Jones Erin is holding 20,000 shares at $11,140 based on the most recent closing price.

Stock Fundamentals for GRTS

Current profitability levels for the company are sitting at:

  • -164.19 for the present operating margin
  • +69.18 for the gross margin

The net margin for Gritstone bio Inc. stands at -160.72. Equity return is now at value -56.50, with -44.00 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 5.52.